Yuki Tsuji

864 total citations
43 papers, 450 citations indexed

About

Yuki Tsuji is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yuki Tsuji has authored 43 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 19 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Yuki Tsuji's work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Yuki Tsuji is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Yuki Tsuji collaborates with scholars based in Japan and Finland. Yuki Tsuji's co-authors include Hitoshi Yoshiji, Tadashi Namisaki, Kosuke Kaji, Takemi Akahane, Hideto Kawaratani, Hiroaki Takaya, Yukihisa Fujinaga, Kei Moriya, Yasuhiko Sawada and Koh Kitagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Medicine.

In The Last Decade

Yuki Tsuji

41 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuki Tsuji Japan	14	198	154	125	100	61	43	450
Chunhua Lin China	11	191 1.0×	58 0.4×	119 1.0×	176 1.8×	63 1.0×	33	491
Hiroshi Tobita Japan	13	193 1.0×	80 0.5×	159 1.3×	184 1.8×	72 1.2×	41	524
Naotaka Shimozato Japan	13	177 0.9×	158 1.0×	58 0.5×	70 0.7×	22 0.4×	34	342
Bing Zhu China	14	189 1.0×	193 1.3×	118 0.9×	104 1.0×	81 1.3×	59	498
İbrahim Hatemı Türkiye	15	286 1.4×	88 0.6×	141 1.1×	63 0.6×	171 2.8×	78	720
Jung‐Min Lee South Korea	11	206 1.0×	122 0.8×	60 0.5×	148 1.5×	40 0.7×	37	526
Víctor Sapena Spain	12	228 1.2×	222 1.4×	74 0.6×	59 0.6×	33 0.5×	35	422
Lukas Unger Austria	16	217 1.1×	172 1.1×	200 1.6×	40 0.4×	47 0.8×	47	581
Shinji Iwane Japan	11	241 1.2×	237 1.5×	76 0.6×	65 0.7×	23 0.4×	34	425
Hati̇ce Karaman Türkiye	13	140 0.7×	59 0.4×	84 0.7×	48 0.5×	48 0.8×	56	449

Countries citing papers authored by Yuki Tsuji

Since Specialization

Citations

This map shows the geographic impact of Yuki Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Tsuji more than expected).

Fields of papers citing papers by Yuki Tsuji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Tsuji. The network helps show where Yuki Tsuji may publish in the future.

Co-authorship network of co-authors of Yuki Tsuji

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Tsuji. A scholar is included among the top collaborators of Yuki Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Tsuji. Yuki Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsuji, Yuki, Naoki Sunagawa, Kiyohiko Igarashi, et al.. (2024). Acetyl Cellooligosaccharide-Based Block Copolymers for Toughening Cellulose Triacetate/Poly(ε-caprolactone) Biodegradable Blends. ACS Sustainable Chemistry & Engineering. 12(8). 3025–3033. 4 indexed citations

Sato, Takeshi, Takeshi Matsumoto, Hideki Kunichika, et al.. (2024). Effects of Short-Term Lenvatinib Administration Prior to Transarterial Chemoembolization for Hepatocellular Carcinoma. Cancers. 16(9). 1624–1624. 2 indexed citations

Suzuki, Junya, Kosuke Kaji, Norihisa Nishimura, et al.. (2023). A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation. Biomedicines. 11(5). 1295–1295. 5 indexed citations

Takaya, Hiroaki, Tadashi Namisaki, Takahiro Kubo, et al.. (2023). The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology. 12(2). 164–164. 4 indexed citations

Tanaka, Misako, Takemi Akahane, Hideto Kawaratani, et al.. (2023). Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B. Hepatology Research. 54(3). 252–260. 1 indexed citations

Iwai, Satoshi, Kosuke Kaji, Norihisa Nishimura, et al.. (2023). Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(7). 166770–166770. 27 indexed citations

Kaji, Kosuke, Norihisa Nishimura, Takahiro Kubo, et al.. (2023). Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin. The Journal of Nutritional Biochemistry. 122. 109450–109450. 9 indexed citations

Takaya, Hiroaki, Tadashi Namisaki, Shohei Asada, et al.. (2022). ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability. Journal of Clinical Medicine. 11(7). 1835–1835. 7 indexed citations

Fujinaga, Yukihisa, Tadashi Namisaki, Yuki Tsuji, et al.. (2022). Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis. International Journal of Molecular Sciences. 23(17). 9814–9814. 2 indexed citations

10.

Namisaki, Tadashi, Yuki Tsuji, Mitsuteru Kitade, et al.. (2022). Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy. In Vivo. 36(3). 1477–1484.

11.

Akahane, Takemi, Daisuke Kaya, Ryuichi Noguchi, et al.. (2021). Association between Equol Production Status and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 22(21). 11904–11904. 8 indexed citations

12.

Takaya, Hiroaki, Tadashi Namisaki, Soichi Takeda, et al.. (2021). The Combination of Albumin–Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child–Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria. Journal of Clinical Medicine. 10(21). 4838–4838. 6 indexed citations

13.

Nishimura, Norihisa, Kosuke Kaji, Koh Kitagawa, et al.. (2021). Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. International Journal of Molecular Sciences. 22(13). 6921–6921. 30 indexed citations

14.

Fujinaga, Yukihisa, Hideto Kawaratani, Daisuke Kaya, et al.. (2020). Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 21(15). 5589–5589. 29 indexed citations

15.

Takaya, Hiroaki, Tadashi Namisaki, Shinya Sato, et al.. (2020). Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure. Journal of Clinical Medicine. 9(5). 1467–1467. 7 indexed citations

16.

Tsuji, Yuki, Kosuke Kaji, Mitsuteru Kitade, et al.. (2020). Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis. Microorganisms. 8(6). 925–925. 19 indexed citations

17.

Kitade, Mitsuteru, Kosuke Kaji, Norihisa Nishimura, et al.. (2019). Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model. Hepatology Research. 49(9). 1034–1045. 6 indexed citations

18.

Takaya, Hiroaki, Tadashi Namisaki, Mitsuteru Kitade, et al.. (2019). Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients. World Journal of Gastrointestinal Oncology. 11(10). 887–897. 5 indexed citations

19.

Tsuji, Yuki, Hideto Kawaratani, Koji Ishida, et al.. (2019). Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia. Digestive Diseases. 38(4). 329–334. 4 indexed citations

20.

Ono, Shigeru, et al.. (2018). Pitfalls in the management of congenital tracheal stenosis: is conservative management feasible?. Pediatric Surgery International. 34(10). 1035–1040. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact